Full Name | Joshua Knight |
---|---|
Gender | Male |
Speciality | Physician Assistant |
Experience | 8 Years |
Location | 197 Nc-42, Asheboro, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1932651452 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363A00000X | Physician Assistant | 0010-06841 (North Carolina) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Fastmed Urgent Care Pc | 9133301989 | 102 |
News Archive
Revealing another part of the story of muscle development, Johns Hopkins researchers have shown how the cytoskeleton from one muscle cell builds finger-like projections that invade into another muscle cell's territory, eventually forcing the cells to combine.
A new study found that treatment-resistant epilepsy (TRE) is common in idiopathic autism. Early age at the onset of seizures and delayed global development were associated with a higher frequency of resistance to antiepileptic drugs (AEDs). Full findings appear online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy (ILAE).
The American Association for the Study of Liver Diseases, in partnership with the Infectious Diseases Society of America and in collaboration with the International Antiviral Society-USA, created online Recommendations for Testing, Managing, and Treating Hepatitis C in 2014 to aid practitioners treating patients infected with hepatitis C virus (HCV).
A new actuarial analysis by Oliver Wyman, Inc. finds that average annual medical claims in the new individual market will be 54 percent higher than they are today five years after implementation of healthcare reform under the Patient Protection and Affordable Care Act (PPACA), excluding the impact of medical inflation.
The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk category and numerical score to assess a patient's risk of distant recurrence at ten years in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), Hormone Receptor-Positive (HR+) breast cancer.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Joshua Knight, 550 White Oak St, Asheboro, NC 27203-4710 Ph: (336) 483-3001 | Joshua Knight, 197 Nc-42, Asheboro, NC 27203 Ph: (336) 625-2560 |
News Archive
Revealing another part of the story of muscle development, Johns Hopkins researchers have shown how the cytoskeleton from one muscle cell builds finger-like projections that invade into another muscle cell's territory, eventually forcing the cells to combine.
A new study found that treatment-resistant epilepsy (TRE) is common in idiopathic autism. Early age at the onset of seizures and delayed global development were associated with a higher frequency of resistance to antiepileptic drugs (AEDs). Full findings appear online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy (ILAE).
The American Association for the Study of Liver Diseases, in partnership with the Infectious Diseases Society of America and in collaboration with the International Antiviral Society-USA, created online Recommendations for Testing, Managing, and Treating Hepatitis C in 2014 to aid practitioners treating patients infected with hepatitis C virus (HCV).
A new actuarial analysis by Oliver Wyman, Inc. finds that average annual medical claims in the new individual market will be 54 percent higher than they are today five years after implementation of healthcare reform under the Patient Protection and Affordable Care Act (PPACA), excluding the impact of medical inflation.
The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk category and numerical score to assess a patient's risk of distant recurrence at ten years in postmenopausal women with node-negative (Stage I or II) or node-positive (Stage II), Hormone Receptor-Positive (HR+) breast cancer.
› Verified 8 days ago
Brian Conrad, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 503 N Fayetteville St, Asheboro, NC 27203 Phone: 336-460-0794 | |
Kaitlin Michele West, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 713 S Fayetteville St, Asheboro, NC 27203 Phone: 336-625-2467 | |
Jamie Webb Robinson, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 197 North Carolina 42 East, White Oak Urgent Care, Asheboro, NC 27203 Phone: 336-625-2560 | |
Amber Nodal, P.A.-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 364 White Oak St, Asheboro, NC 27203 Phone: 336-625-5151 | |
Holly Marie O'grady Vanbencoten, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1714 Back Creek Ct, Asheboro, NC 27205 Phone: 704-796-1309 | |
Kelly J Trogdon, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 360 Sunset Ave, Asheboro, NC 27203 Phone: 336-625-8410 Fax: 336-625-8405 | |
Julie A Jasienowski, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 364 White Oak St, Asheboro, NC 27203 Phone: 800-815-7491 Fax: 843-237-9736 |